80 results on '"Sener, Ugur"'
Search Results
2. Isocitrate Dehydrogenase Inhibitors in Glioma: From Bench to Bedside
3. Intravascular Lymphoma with Central Nervous System Involvement: Mayo Clinic Experience (P4-5.023)
4. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis
5. Novel Clinical Trials and Approaches in the Management of Glioblastoma
6. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas
7. Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design
8. Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis
9. Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions
10. Tumors of the Nervous System
11. NCOG-39. DOSE-EFFECT RELATIONSHIP OF DEXAMETHASONE ON OUTCOMES OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
12. CTIM-33. EFFICACY AND SAFETY STUDY OF NEOADJUVANT EFINEPTAKIN ALFA (NT-I7) AND PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA
13. RADT-05. SINGLE VERSUS MULTI-FRACTION STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES: RATES OF LOCAL PROGRESSION AND NECROSIS
14. NCMP-20. ASSESSING THE IMPACT OF DRIVER MUTATIONS AND ANTINEOPLASTIC TREATMENTS ON RISK FOR STROKE RECURRENCE IN PATIENTS WITH LUNG ADENOCARCINOMA
15. RADT-18. PROTON CRANIOSPINAL IRRADIATION WITH CHECKPOINT INHIBITOR THERAPY FOR PATIENTS WITH LEPTOMENINGEAL DISEASE FROM SOLID TUMORS – A SINGLE INSTITUTION CASE SERIES
16. NCOG-37. BELZUTIFAN IN ADULTS WITH VHL-ASSOCIATED CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMA: A SINGLE-CENTER EXPERIENCE
17. NCOG-18. CLINICAL CHARACTERISTICS OF H3.G34 DIFFUSE HEMISPHERIC GLIOMA: A CASE SERIES AND REVIEW OF THE LITERATURE
18. CTNI-03. EFFICACY OF WSD0922-FU IN OSIMERTINIB-RESISTANT NSCLC WITH CENTRAL NERVOUS SYSTEM (CNS) METASTASES – UPDATES FROM THE DOSE ESCALATION COHORT OF A FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL (MC1914)
19. QLTI-07. DOSE-EFFECT RELATIONSHIP OF DEXAMETHASONE ON OUTCOMES OF BRAIN METASTASES
20. Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma
21. Management and Long-term Outcomes of Adults With Medulloblastoma
22. Spinal Meningeal Mass Lesion
23. Intracranial intraoperative radiotherapy (IORT): evaluation of electrocorticography and peri-operative seizure risk
24. Safety of intravenous thrombolysis for ischemic stroke in patients with hematologic malignancies: A single institution experience
25. Glomus coccygeum masquerading as chordoma
26. A Rare Case of Glioblastoma with Osseous Metastases
27. Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
28. Teaching NeuroImage: Intracranial Solitary Fibrous Tumor With Liver Metastasis
29. Rare Cortical and Intraparenchymal Epidermoid Cyst within the Right Occipital Lobe (P3-4.004)
30. The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
31. Leptomeningeal anti-tumor immunity follows unique signaling principles
32. Rare Cortical and Intraparenchymal Epidermoid Cyst within the Right Occipital Lobe
33. Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients
34. INNV-15. MANAGEMENT AND LONG-TERM OUTCOMES OF ADULTS WITH MEDULLOBLASTOMA
35. NCOG-35. A SINGLE INSTITUTION SERIES ON PINEAL PARENCHYMAL TUMORS OF INTERMEDIATE DIFFERENTIATION (PPTID)
36. NIMG-96. SPINAL MENINGEAL MASS LESION: A RARE PRESENTATION OF FOLLICULAR LYMPHOMA
37. Ischemic Stroke in Patients With Malignancy
38. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis
39. Teaching NeuroImage: Horizontal Diplopia Due to Extraocular Muscle Metastasis
40. Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
41. RARE-10. Neurocutaneous melanocytosis-associated hydrocephalus: the MSK experience from 2001-2022
42. Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
43. Cancer cells outcompete macrophages for extracellular iron in leptomeningeal metastasis
44. Advances in the diagnosis, evaluation, and management of leptomeningeal disease
45. Histone-mutant glioma presenting as diffuse leptomeningeal disease
46. Neurocutaneous melanocytosis‐associated malignant melanoma presenting with peritoneal seeding
47. LMD-16. Choroid plexus orchestrates anti-cancer immunity in leptomeninges
48. RADI-08. Elucidating the Electrophysiology of Intraoperative Radiotherapy – Experience from Two Cases
49. Forecasting of the U.S. Steel Prices with LVAR and VEC Models
50. Abstract 1751: Decoding the immune system response to leptomeningeal metastasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.